Real-world findings of daridorexant in chronic insomnia: A pilot study on subjective and actigraphic sleep parameters
- 13 February 2026
- journal article
- research article
- Published by Elsevier in Sleep Medicine
- Vol. 142, 108839
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus GroupJournal of Neurology, 2023
- Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia DisorderCNS Drugs, 2022
- Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled TrialDrugs & Aging, 2022
- Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)The Patient - Patient-Centered Outcomes Research, 2020
- Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia DisorderAnnals of Neurology, 2020
- Validation study of the Italian version of the Insomnia Severity Index (ISI)Neurological Sciences, 2016
- Gender differences in the effect of comorbid insomnia symptom on depression, anxiety, fatigue, and daytime sleepiness in patients with obstructive sleep apneaSleep and Breathing, 2013
- Validity of the Italian Version of the Pittsburgh Sleep Quality Index (PSQI)Neurological Sciences, 2012
- Italian version of the Epworth sleepiness scale: external validityNeurological Sciences, 2003
- The phenomenology of the pre-sleep state: The development of the pre-sleep arousal scaleBehaviour Research and Therapy, 1985